期刊文献+

原位肝移植治疗急性肝功能衰竭21例临床分析 被引量:5

Liver transplantation for acute hepatic failure:a report of 21 cases
原文传递
导出
摘要 目的探讨原位肝移植治疗急性肝功能衰竭的临床疗效。方法回顾性分析天津市第一中心医院21例因急性肝功能衰竭行原位肝脏移植术病人的临床资料,总结急性肝衰竭实施肝移植的经验。结果21例病人随访时间为3~60个月,中位随访时间为25个月。生存时间为1—1530d,中位生存时间为517d。病人的围手术期存活率为66.7%,1年存活率为66.7%,2年存活率为66.7%。死亡原因包括多脏器功能衰竭、颅内出血、上消化道出血、急性成人呼吸窘迫综合征、移植物原发性无功能。14例的远期性生存病人中,13例移植前合并乙型肝炎(乙肝),其中有1例(1/13)在术后1年出现乙肝复发。结论肝移植术是治疗急性肝功能衰竭最有效的方法,严格把握适应证、合理选择手术时机是提高疗效的关键。 Objective To investigate the effect of orthotropic liver transplantation(OLT) in treatment for acute hepatic failure (AHF) patients. Methods A retrospective review was undertaken on the clinical data of 21case undergoing liver transplantation for AHF. Results In 21case, the follow-up time was 3 to 60 months with the median follow-up time as 25 months. The survival time was 1 to 1 530 days with the median as 517dyas. The one month survival rate was 66. 7% ,and the 1 year and 2year survival rate were 66. 7% the same. The causes of death cases were included:infection, multiple organ failure, acute respirator distress syndrome, intracalvarium hemorrhage, upper digestive tract hemorrhage and primary non-function. One of the 13 HBV relative was HBV recurrence in one year after OLT. Conclusion Liver transplantation was effective in the treatment of AHF. The key points to elevate the effect were strict indication and good operation opportunity.
出处 《中国实用外科杂志》 CSCD 北大核心 2007年第1期75-77,共3页 Chinese Journal of Practical Surgery
基金 China Medical Boardin New York(No.06837)
关键词 原位肝移植 急性肝功能衰竭 Orthotropic liver transplantation Acute Hepatic Failure
  • 相关文献

参考文献2

二级参考文献96

  • 1[55]Caty MG,Guice KS,Oldham KT,Remick DG,Kunkel SI.Evidence for tumor necrosis factor-induced pulmonary microvascular injury after intestinal ischemia-reperfusion injury.Ann Surg 1990; 212:694-700
  • 2[56]Horie Y,Wolf R,Russell J,Shanley TP,Granger DN.Role of Kupffer cells in gut ischemia/reperfusion-induced hepatic microvascular dysfunction in mice.Hepatology 1997; 26:1499-1505
  • 3[57]Obi-Tabot ET,Hanrahan LM,Cachecho R,Beer ER,Hopkins SR,Chan JC,Shapiro JM,LaMorte WW.Changes in hepatocyte NADH fluorescence during prolonged hypoxia.J Surg Res 1993; 55:575-580
  • 4[58]Eppihimer MJ,Wolitzky B,Anderson DC,Labow MA,Granger DN.Heterogeneity of expression of E-and P-selectins in vivo.Circ Res 1996; 79:560-569
  • 5[59]Mustafa SB,Flickinger BD,Olson MS.Suppression of lipopolysaccharide-induced nitric oxide synthase expression by platelet-activating factor receptor antagonists in the rat liver and cultured rat Kupffer cells.Hepatology 1999; 30:1206-1214
  • 6[60]Ghosh S,Baltimore D.Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B.Nature 1990; 344:678-682
  • 7[61]Pearson JM,Bailie MB,Fink GD,Roth RA.Neither platelet activating factor nor leukotrienes are critical mediators of liver injury after lipopolysaccharide administration.Toxicology 1997;121:181-189
  • 8[62]Murohisa G,Kobayashi Y,Kawasaki T,Nakamura S,Nakamura H.Involvement of platelet-activating factor in hepatic apoptosis and necrosis in chronic ethanol-fed rats given endotoxin.Liver 2002; 22:394-403
  • 9[63]Howard KM,Olson MS.The expression and localization of plasma platelet-activating factor acetylhydrolase in endotoxemic rats.J Biol Chem 2000; 275:19891-19896
  • 10[64]Zhang F.Protective effect of a platelet activating factor antagonist in experimental liver injury.Zhonghua Yixue Zazhi 1990;70:375-378,26

共引文献9

同被引文献80

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部